p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia

Na Man(ShanghaiTech University), Stephen D. Nimer(University of Miami)

JCI Insight

October 7, 2021

10.1172/jci.insight.138478

Cited by 19

Related Papers

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

|Blood|2001|427

Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma

|Journal of Clinical Oncology|1999|303

An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia

|Cancer Cell|2012|276

High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis

|Blood|2000|120

The SWI/SNF chromatin-remodeling subunit DPF2 facilitates NRF2-dependent antiinflammatory and antioxidant gene expression

|Journal of Clinical Investigation|2023|19